210 related articles for article (PubMed ID: 27687785)
1. An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders.
Nguyen TT; Pariente A; Montastruc JL; Lapeyre-Mestre M; Rousseau V; Rascol O; Bégaud B; Montastruc F
Br J Clin Pharmacol; 2017 Mar; 83(3):612-622. PubMed ID: 27687785
[TBL] [Abstract][Full Text] [Related]
2. Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.
Montastruc F; Palmaro A; Bagheri H; Schmitt L; Montastruc JL; Lapeyre-Mestre M
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1556-65. PubMed ID: 26256010
[TBL] [Abstract][Full Text] [Related]
3. The association between receptor binding affinity and metabolic side effect profile of antipsychotics and major cardio- and cerebrovascular events: A case/non-case study using VigiBase.
Aguiar JP; Alves da Costa F; Egberts T; Leufkens H; Souverein P
Eur Neuropsychopharmacol; 2020 Jun; 35():30-38. PubMed ID: 32409260
[TBL] [Abstract][Full Text] [Related]
4. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
Svendsen K; Wood M; Olsson E; Nordeng H
Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
[TBL] [Abstract][Full Text] [Related]
5. Withdrawal syndrome after antipsychotics discontinuation: an analysis of the WHO database of spontaneous reports (Vigibase) between 2000 and 2022.
Storck W; de Laportalière TT; Yrondi A; Javelot H; Berna F; Montastruc F
Psychopharmacology (Berl); 2024 Jun; 241(6):1205-1212. PubMed ID: 38376511
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
[TBL] [Abstract][Full Text] [Related]
7. Detecting a potential safety signal of antidepressants and type 2 diabetes: a pharmacovigilance-pharmacodynamic study.
Siafis S; Papazisis G
Br J Clin Pharmacol; 2018 Oct; 84(10):2405-2414. PubMed ID: 29953643
[TBL] [Abstract][Full Text] [Related]
8. Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions.
Sekine Y; Rikihisa T; Ogata H; Echizen H; Arakawa Y
Eur J Clin Pharmacol; 1999 Oct; 55(8):583-7. PubMed ID: 10541776
[TBL] [Abstract][Full Text] [Related]
9. Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database.
Revet A; Montastruc F; Roussin A; Raynaud JP; Lapeyre-Mestre M; Nguyen TTH
BMC Psychiatry; 2020 Jun; 20(1):308. PubMed ID: 32546134
[TBL] [Abstract][Full Text] [Related]
10. β-adrenoceptor antagonists and nightmares: A pharmacoepidemiological-pharmacodynamic study.
Garcia P; Montastruc JL; Rousseau V; Hamard J; Sommet A; Montastruc F
J Psychopharmacol; 2021 Dec; 35(12):1441-1448. PubMed ID: 34318729
[TBL] [Abstract][Full Text] [Related]
11. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study.
Cepaityte D; Siafis S; Egberts T; Leucht S; Kouvelas D; Papazisis G
Schizophr Bull; 2021 Apr; 47(3):672-681. PubMed ID: 33289848
[TBL] [Abstract][Full Text] [Related]
12. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
Seeman P; Tallerico T
Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
[TBL] [Abstract][Full Text] [Related]
14. Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase
Nguyen TTH; Roussin A; Rousseau V; Montastruc JL; Montastruc F
Drug Saf; 2018 Nov; 41(11):1087-1096. PubMed ID: 29956218
[TBL] [Abstract][Full Text] [Related]
15. Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
Sagwa EL; Souverein PC; Ribeiro I; Leufkens HG; Mantel-Teeuwisse AK
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):1-8. PubMed ID: 27868278
[TBL] [Abstract][Full Text] [Related]
16. Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase.
Mannesse CK; van Puijenbroek EP; Jansen PA; van Marum RJ; Souverein PC; Egberts TC
Drug Saf; 2010 Jul; 33(7):569-78. PubMed ID: 20553058
[TBL] [Abstract][Full Text] [Related]
17. Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase(®).
Montastruc F; Salvo F; Arnaud M; Bégaud B; Pariente A
Drug Saf; 2016 Jul; 39(7):689-96. PubMed ID: 26961536
[TBL] [Abstract][Full Text] [Related]
18. Safety profile of H1-antihistamines in pediatrics: an analysis based on data from VigiBase.
Motola D; Donati M; Biagi C; Calamelli E; Cipriani F; Melis M; Monaco L; Vaccheri A; Ricci G
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1164-1171. PubMed ID: 28653802
[TBL] [Abstract][Full Text] [Related]
19. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years.
Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S
Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological considerations in antipsychotic drug selection for prevention of drug-induced dysphagia.
Koshiishi T; Koinuma M; Takagi A; Nakamura H
Pharmazie; 2020 Nov; 75(11):595-598. PubMed ID: 33239136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
